Search Results

There are 2020845 results for: content related to: Examining Braak's hypothesis by imaging Parkinson's disease

  1. Milestones in Parkinson's disease—Clinical and pathologic features

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 1015–1021, Glenda Halliday, Andrew Lees and Matthew Stern

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23669

  2. A critical evaluation of the Braak staging scheme for Parkinson's disease

    Annals of Neurology

    Volume 64, Issue 5, November 2008, Pages: 485–491, Robert E. Burke, William T. Dauer and Jean Paul G. Vonsattel

    Article first published online : 9 DEC 2008, DOI: 10.1002/ana.21541

  3. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study

    Annals of Neurology

    Volume 51, Issue 5, May 2002, Pages: 567–577, Kathryn P. Riley, David A. Snowdon and William R. Markesbery

    Article first published online : 8 MAR 2002, DOI: 10.1002/ana.10161

  4. Non-Dopaminergic Pathology of Parkinson's Disease

    Parkinson's Disease: Non-Motor and Non-Dopaminergic Features

    Heiko Braak, Kelly Del Tredici, Pages: 15–31, 2011

    Published Online : 27 JUN 2011, DOI: 10.1002/9781444397970.ch3

  5. The Metabolism of [18F]6-Fluoro-l-3,4-Dihydroxyphenylalanine in the Hooded Rat

    Journal of Neurochemistry

    Volume 48, Issue 2, February 1987, Pages: 601–608, P. Dimming, B. E. Boyes, W. R. W. Martin, M. Adam, J. Grierson, T. Ruth and E. G. McGeer

    Article first published online : 5 OCT 2006, DOI: 10.1111/j.1471-4159.1987.tb04135.x

  6. Use of functional imaging in parkinsonism and dementia

    Movement Disorders

    Volume 18, Issue S6, September 2003, Pages: 88–95, David J. Burn and John T. O'Brien

    Article first published online : 4 SEP 2003, DOI: 10.1002/mds.10568

  7. Imaging end points for monitoring neuroprotection in Parkinson's disease

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S110–S119, David J. Brooks

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10480

  8. Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

    Movement Disorders

    Volume 27, Issue 1, January 2012, Pages: 8–30, Kurt A. Jellinger

    Article first published online : 11 NOV 2011, DOI: 10.1002/mds.23795

  9. When does Parkinson's disease begin?

    Movement Disorders

    Volume 24, Issue S2, 2009, Pages: S656–S664, Carles Gaig and Eduardo Tolosa

    Article first published online : 28 OCT 2009, DOI: 10.1002/mds.22672

  10. Milestones in neuroimaging

    Movement Disorders

    Volume 26, Issue 6, May 2011, Pages: 868–978, A. Jon Stoessl, David J. Brooks and David Eidelberg

    Article first published online : 27 MAY 2011, DOI: 10.1002/mds.23679

  11. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?

    Movement Disorders

    Volume 18, Issue S7, October 2003, Pages: S43–S51, Walter Pirker

    Article first published online : 26 SEP 2003, DOI: 10.1002/mds.10579

  12. Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study

    Annals of Neurology

    Volume 41, Issue 2, February 1997, Pages: 222–229, Dr P. Piccini, P. K. Morrish, N. Turjanski, G. V. Sawle, D. J. Burn, R. A. Weeks, M. H. Mark, D. M. Maraganore, A. J. Lees and D. J. Brooks

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410410213

  13. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

    Annals of Neurology

    Volume 28, Issue 4, October 1990, Pages: 547–555, Dr D. J. Brooks, V. Ibanez, G. V. Sawle, N. Quinn, A. J. Lees, C. J. Mathias, R. Bannister, C. D. Marsden and R. S. J. Frackowiak

    Article first published online : 8 OCT 2004, DOI: 10.1002/ana.410280412

  14. Convenient Synthesis of Diaryliodonium Salts for the Production of [18F]F-DOPA

    European Journal of Organic Chemistry

    Volume 2015, Issue 3, January 2015, Pages: 625–630, Richard Edwards, Andrew D. Westwell, Stephen Daniels and Thomas Wirth

    Article first published online : 9 DEC 2014, DOI: 10.1002/ejoc.201403378

  15. The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?

    Movement Disorders

    Volume 23, Issue 13, 15 October 2008, Pages: 1799–1807, Christopher H. Hawkes

    Article first published online : 29 AUG 2008, DOI: 10.1002/mds.22242

  16. Do dopamine agonists or levodopa modify Parkinson's disease progression?

    European Journal of Neurology

    Volume 9, Issue s3, November 2002, Pages: 15–22, K. Marek, D. Jennings and J. Seibyl

    Article first published online : 11 DEC 2002, DOI: 10.1046/j.1468-1331.9.s3.2.x

  17. Dopamine agonists and Parkinson's disease progression: What can we learn from neuroimaging studies

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S160–S169, Kenneth Marek, Danna Jennings and John Seibyl

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10486

  18. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

    Annals of Neurology

    Volume 47, Issue 4, April 2000, Pages: 493–503, Chong S. Lee, Ali Samii, Vesna Sossi, Thomas J. Ruth, Michael Schulzer, James E. Holden, Jess Wudel, Pramod K. Pal, Raul De La Fuente-Fernandez, Donald B. Calne and A. Jon Stoessl

    Article first published online : 26 APR 2001, DOI: 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4

  19. Effect of Vascular Lesions on Cognition in Alzheimer's Disease: A Community-Based Study

    Journal of the American Geriatrics Society

    Volume 52, Issue 9, September 2004, Pages: 1442–1448, Robert G. Riekse, James B. Leverenz, Wayne McCormick, James D. Bowen, Linda Teri, David Nochlin, Kate Simpson, Charisma Eugenio, Eric B. Larson and Debby Tsuang

    Article first published online : 16 AUG 2004, DOI: 10.1111/j.1532-5415.2004.52405.x

  20. You have free access to this content
    Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

    Journal of Neurochemistry

    Volume 93, Issue 1, April 2005, Pages: 105–117, Rebecca J. Griffin, Aileen Moloney, Mary Kelliher, Janet A Johnston, Rivka Ravid, Peter Dockery, Rosemary O'Connor and Cora O'Neill

    Article first published online : 8 FEB 2005, DOI: 10.1111/j.1471-4159.2004.02949.x